Latest Breaking News On - Jenniferl hsiao - Page 1 : comparemela.com

Secukinumab and Bimekizumab for Hidradenitis Suppurativa

Patients with HS are getting a long-awaited influx of targeted therapies. Jennifer L. Hsiao, MD, discusses their immediate impact.

Jenniferl hsiaoSociety for dermatology physician assistantsKeck school of medicineDrug administrationDermatology physician assistantsKeck schoolHidradenitis suppurativa clinical response

How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?

Jennifer L. Hsiao, MD, discusses what the anticipated JAK inhibitors may provide to patients with HS if FDA-approved in the coming years.

Jenniferl hsiaoJohn frewDrug administrationKeck school of medicineSociety for dermatology physician assistantsDermatology physician assistantsKeck schoolHidradenitis suppurativa clinical response

Experts Share Practical Tips for Diagnosing Mild HS

Experts Share Practical Tips for Diagnosing Mild HS
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of north carolinaNorth carolinaChapel hillChristopher sayedJenniferl hsiaoLos angelesUniversity of southern californiaNhs foundationCanadian hidradenitis suppurativa foundationsFollicular disorders clinicRecurrence majorDermatology life quality indexMedscape medicalSouthern californiaGlobal assessment

Patient Preferences Drive Treatment Options for Early HS

Patient Preferences Drive Treatment Options for Early HS
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

United statesLos angelesJenniferl hsiaoChristopher sayedAmerican academy of dermatologyUniversity of southern californiaUniversity of north carolinaFollicular disorders clinicNorth carolinaChapel hillSouthern californiaAmong optionsRuxolitinib creamAmerican academy

Novel Drug Shows Promise for Hidradenitis Suppurativa

The findings suggest that Bruton's tyrosine kinase inhibition may emerge as a promising therapeutic intervention in HS.

Harvard universityUnited statesAlexab kimballJenniferl hsiaoLos angelesClinical laboratory for epidemiologyUniversity of southern californiaAmerican academy of dermatologyClinical laboratoryApplied researchBeth israel deaconess medical centerAmerican academyHidradenitis suppurativa clinical responseGlobal assessmentSkin pain numeric rating scaleSouthern california